Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;29(1):33-41.
doi: 10.1111/tmi.13950. Epub 2023 Nov 29.

Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea

Dylan R Rice  1 , Carlos Othon Guelngar  2 , Mohamed Traoré  2 , Mohamed Laminé Condé  2 , Djenabou Diallo  2 , Nathanael J Lee  3 , Andrew Siyoon Ham  1 , Fodé Abass Cissé  2 , Farrah J Mateen  1   4 ; Guinea Epilepsy Project
Affiliations
Free article

Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea

Dylan R Rice et al. Trop Med Int Health. 2024 Jan.
Free article

Abstract

Background and objective: Of ~5 million people living with epilepsy (PLWE) in Sub-Saharan Africa, roughly one-third experience depression and over one third experience anxiety. In Guinea, these issues may be compounded by fewer available resources, such as appropriate anti-seizure medications (ASMs). We aim to quantify seizure frequency, anxiety and depression in PLWE in Guinea, before and after a free ASM intervention and neurologist's consultation.

Methods: Guinean participants >12 years old with ≥2 unprovoked seizure were prospectively recruited. As part of a broader interview, participants reported prior 30-day seizure frequency and screened for depression (PHQ-9) (range 0-27 points) and anxiety (GAD-7) (range 0-21 points) with re-evaluation at 90 days.

Results: Of 148 participants enrolled (mean age = 27.3 years, range 12-72; 45% female), 62% were currently taking ASMs. For the 30 days pre-enrolment, average seizure frequency was 3.2 (95%CI 2.3, 4.2); 28% of participants were seizure-free. ASM regimens were modified for 95% of participants, mostly initiating levetiracetam (n = 115, 80% of modifications). 90-day study retention was 76% (n = 113) among whom 87% reported full adherence to the ASM. After 90 days, the average seizure frequency over the prior 30 days was 1.5 (95%CI 0.5, 2.6), significantly lower than at baseline (p = 0.002). 66% were seizure-free. At baseline, average PHQ-9 score was 21.2 (95%CI [20.2, 22.2]), indicating severe depressive symptoms. Average GAD-7 score was 16.5 [15.6, 17.4], indicating severe anxious symptoms. At 90-days, average PHQ-9 score was 17.5[16.4, 18.5] and significantly lower than baseline (p < 0.001). Average GAD-7 score was 14.4 [13.6, 15.3] and significantly lower than baseline (p = 0.002). Seizure frequency was not correlated with PHQ-9 nor GAD-7 scores at baseline but was at 90 days for both PHQ-9 (r = 0.24, p = 0.01) and GAD-7 (r = 0.22, p = 0.02) scores. The prevalence of suicidal ideation dropped from 67% to 47% of participants (p = 0.004).

Discussion: ASM management has dual importance for PLWE in resource-limited settings, improving both seizure control and mental health.

Keywords: Africa; anxiety; depression; epilepsy; global health; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Ba-Diop A, Marin B, Druet-Cabanac M, Ngoungou EB, Newton CR, Preux PM. Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol. 2014;13(10):1029-1044. https://doi.org/10.1016/S1474-4422(14)70114-0
    1. Dessie G, Mulugeta H, Leshargie CT, Wagnew F, Burrowes S. Depression among epileptic patients and its association with drug therapy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2019;14(3):e0202613. https://doi.org/10.1371/journal.pone.0202613
    1. Nigussie K, Lemma A, Sertsu A, Asfaw H, Kerebih H, Abdeta T. Depression, anxiety and associated factors among people with epilepsy and attending outpatient treatment at primary public hospitals in northwest Ethiopia: a multicenter cross-sectional study. PLoS One. 2021;16(8):e0256236. https://doi.org/10.1371/journal.pone.0256236
    1. Kwon OY, Park SP. Depression and anxiety in people with epilepsy. J Clin Neurol. 2014 Jul 3;10(3):175-188.
    1. Seid J, Mebrahtu K, Andualem F. Prevalence and associated factors of anxiety disorder symptoms among people with epilepsy in Mekelle, Ethiopia, 2019: institutional-based cross-sectional study. Nurs Open. 2022 May;9(3):1731-1743.